Bullish Moving Averages
8
Bearish Moving Averages
8
Back Stocks profile
Stock analysis tool for investors
Open an Account with Bigul in 5 minutes
Performance
Today’s low
1195.30Today’s High
1245.6052W low
825.0052W High
1541.60Open Price
1240.00Prev. Close
1086.7500Volume
30020.00Value
36130571.00Fundamentals
Market Cap Cr
2360.10
Price to Earnings
-50.30
Price to Book Value
6.40
Dividend Yield
0.10
PE to Growth
0.20
Op Revenue TTM Cr
458.18
Net Profit TTM Cr
-46.93
Cash From Operating Activity Cr
10.22
Return on Equity %
-12.70
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
07 May, 2024
48.3
Week
37.2
Month
48.1
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
1214.80
PIVOT
First Resistance
1234.30
Second Resistance
1265.05
Third Resistance
1284.55
First Support
1184.05
Second Support
1164.55
Third Support
1133.80
Relative Strength Index
50.21
Money Flow Index
60.17
MACD
30.03
MACD Signal
43.31
Average True Range
61.66
Average Directional Index
45.76
Rate of Change (21)
5.41
Rate of Change (125)
-3.87
Commodity Channel Index
-137.2
Williams %R
-96.1
BETA
1 Month
1.42
3 Month
0.5
1 Year
0.12
3 Year
0.1
PRICE CHANGE ANALYSIS
↓ -2.21%
1 Week
Low
High
1195.3
1406.6
↓ -0.18%
1 Month
Low
High
1187
1406.6
↑ 32.35%
3 Months
Low
High
825.05
1406.6
↓ -4.89%
6 Months
Low
High
825.05
1406.6
↓ -11.65%
1 Year
Low
High
825.05
1541.65
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 155.78 | 51.69 | 111.74 | 144.55 | 129.54 | 120.96 | 203.73 | 186.97 | 278.78 | 175.31 | 103.47 | |
| Operating Expenses Qtr | 141.04 | 69.12 | 114.21 | 139.71 | 121.57 | 105.05 | 166.47 | 158.81 | 206.52 | 130.49 | 81.49 | |
| Operating Profit Qtr | 12.71 | -18.33 | -3.42 | 3.14 | 5.40 | 12.13 | 33.28 | 25.45 | 65.46 | 42.86 | 21.08 | |
| EBIDT Qtr Cr | 14.74 | -17.43 | -2.46 | 4.83 | 7.97 | 15.91 | 37.26 | 28.16 | 72.26 | 44.82 | 21.98 | |
| Depreciation Qtr | 9.02 | 8.72 | 9.17 | 9.40 | 7.77 | 8.81 | 8.18 | 8.94 | 10.66 | 9.07 | 8.17 | |
| Net Profit Qtr | -0.99 | -24.35 | -13.45 | -8.21 | -5.00 | 0.83 | 18.30 | 11.39 | 43.04 | 24.74 | 9.06 | |
| Basic EPS Qtr | -0.50 | -12.42 | -6.86 | -4.19 | -2.55 | 0.42 | 9.34 | 5.81 | 21.97 | 12.63 | 4.63 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 463.76 | 641.20 | 687.03 | 562.54 | 534.15 | |
| Operating Expenses Annual Cr | 464.08 | 551.90 | 522.48 | 443.37 | 437.02 | |
| Operating Profit Annual | -5.90 | 76.27 | 154.08 | 111.51 | 85.20 | |
| Operating Profit Margin Annual % | -1.27 | 11.89 | 22.43 | 19.82 | 15.95 | |
| Total Expenses Annual Cr | 525.64 | 606.35 | 565.99 | 473.87 | 472.88 | |
| EBIDT Annual Cr | -0.32 | 89.30 | 164.55 | 119.18 | 97.14 | |
| EBIDT Annual margin % | -0.07 | 13.93 | 23.95 | 21.19 | 18.19 | |
| Depreciation | 36.31 | 33.71 | 34.42 | 25.71 | 23.22 | |
| PAT Before ExtraOrdinary Items Annual Cr | -46.99 | 25.52 | 89.82 | 64.69 | 47.47 | |
| Net Profit Annual | -46.99 | 25.52 | 89.82 | 64.69 | 47.47 | |
| Basic EPS Annual | -23.96 | 13.02 | 45.85 | 33.05 | 24.27 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 368.68 | 418.79 | 395.98 | 308.70 | 246.44 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 208.22 | 33.73 | 9.75 | 46.23 | 6.78 | |
| Total Current Liabilities Annual Cr | 397.25 | 526.33 | 490.98 | 322.97 | 318.88 | |
| Total Capital Plus Liabilities Annual Cr | 974.15 | 978.85 | 896.71 | 677.90 | 572.10 | |
| Fixed Assets Annual | 550.82 | 444.95 | 362.71 | 328.38 | 217.79 | |
| Total Non Current Assets Annual | 576.67 | 480.75 | 378.90 | 347.47 | 240.41 | |
| Total Current Assets Annual | 397.48 | 498.09 | 517.81 | 330.43 | 331.69 | |
| Total Assets Annual | 974.15 | 978.85 | 896.71 | 677.90 | 572.10 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 256.13 | 215.22 | 233.72 | 209.82 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 10.13 | 74.32 | 23.41 | -8.06 | 168.56 | |
| Cash from Investing Activity Annual | -134.98 | -112.07 | -103.57 | -73.11 | -73.81 | |
| Cash from Financing Annual Activity | 124.85 | 37.66 | 80.37 | 81.23 | -94.64 | |
| Net Cash Flow Annual | - | -0.09 | 0.22 | 0.06 | 0.11 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 188.01 | 213.61 | 202.06 | 157.60 | 125.94 | |
| ROE Annual % | -12.74 | 6.09 | 22.68 | 20.95 | 19.26 | |
| ROCE Annual % | -6.34 | 12.28 | 32.07 | 26.33 | 29.18 | |
| Total Debt to Total Equity Annual | 1.34 | 0.81 | 0.71 | 0.61 | 0.40 | |
| EBDIT Annual Margin % | -0.06 | 14.21 | 24.32 | 21.47 | 18.60 |
| Indicator | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 155.80 | 51.70 | 111.77 | 144.56 | 129.55 | 120.97 | 203.73 | 186.98 | 278.79 | 175.31 | 103.47 | |
| Operating Expenses Qtr | 141.04 | 69.13 | 114.21 | 139.72 | 121.57 | 105.06 | 166.47 | 158.82 | 206.52 | 130.49 | 81.49 | |
| Operating Profit Qtr | 12.71 | -18.33 | -3.42 | 3.13 | 5.40 | 12.12 | 33.28 | 25.45 | 65.46 | 42.86 | 21.08 | |
| EBIDT Qtr Cr | 14.76 | -17.42 | -2.44 | 4.84 | 7.98 | 15.91 | 37.26 | 28.16 | 72.27 | 44.82 | 21.98 | |
| Depreciation Qtr | 9.01 | 8.70 | 9.16 | 9.39 | 7.76 | 8.80 | 8.17 | 8.93 | 10.64 | 9.06 | 8.15 | |
| Net Profit Qtr | -0.97 | -24.33 | -13.43 | -8.19 | -4.98 | 0.84 | 18.31 | 11.40 | 43.05 | 24.75 | 9.08 | |
| Basic EPS Qtr | -0.50 | -12.41 | -6.85 | -4.18 | -2.54 | 0.43 | 9.34 | 5.82 | 21.97 | 12.63 | 4.63 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 463.82 | 641.23 | 687.03 | 562.79 | 534.54 | |
| Operating Expenses Annual Cr | 464.09 | 551.91 | 522.49 | 443.32 | 437.43 | |
| Operating Profit Annual | -5.91 | 76.25 | 154.07 | 111.56 | 85.18 | |
| Operating Profit Margin Annual % | -1.27 | 11.89 | 22.43 | 19.82 | 15.93 | |
| Total Expenses Annual Cr | 525.57 | 606.28 | 565.91 | 473.72 | 473.19 | |
| EBIDT Annual Cr | -0.27 | 89.31 | 164.54 | 119.48 | 97.11 | |
| EBIDT Annual margin % | -0.06 | 13.93 | 23.95 | 21.23 | 18.17 | |
| Depreciation | 36.25 | 33.65 | 34.36 | 25.66 | 23.16 | |
| PAT Before ExtraOrdinary Items Annual Cr | -46.89 | 25.59 | 89.88 | 65.07 | 47.53 | |
| Net Profit Annual | -46.93 | 25.56 | 89.86 | 65.05 | 47.51 | |
| Basic EPS Annual | -23.93 | 13.04 | 45.85 | 33.21 | 24.27 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 369.29 | 419.36 | 396.50 | 309.18 | 246.57 | |
| Minority Interest Liability Annual Cr | 0.23 | 0.19 | 0.16 | 0.14 | 0.33 | |
| Total Non Current Liabilities Annual Cr | 208.25 | 33.66 | 9.51 | 45.99 | 6.46 | |
| Total Current Liabilities Annual Cr | 397.16 | 526.20 | 490.59 | 322.28 | 318.36 | |
| Total Capital Plus Liabilities Annual Cr | 974.93 | 979.41 | 896.76 | 677.59 | 571.72 | |
| Fixed Assets Annual | 551.00 | 445.08 | 362.77 | 328.39 | 217.73 | |
| Total Non Current Assets Annual | 576.44 | 480.56 | 381.08 | 347.16 | 239.97 | |
| Total Current Assets Annual | 398.49 | 498.85 | 515.68 | 330.43 | 331.75 | |
| Total Assets Annual | 974.93 | 979.41 | 896.76 | 677.59 | 571.72 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 256.17 | 239.82 | 233.75 | 274.87 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | 10.22 | 74.66 | 23.60 | -8.16 | 168.44 | |
| Cash from Investing Activity Annual | -135.18 | -112.51 | -103.87 | -73.11 | -73.81 | |
| Cash from Financing Annual Activity | 124.96 | 37.77 | 80.48 | 81.34 | -94.53 | |
| Net Cash Flow Annual | - | -0.08 | 0.22 | 0.06 | 0.10 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 188.44 | 214.00 | 202.40 | 157.91 | 126.17 | |
| ROE Annual % | -12.70 | 6.09 | 22.66 | 21.03 | 19.26 | |
| ROCE Annual % | -6.32 | 12.28 | 32.05 | 26.40 | 29.18 | |
| Total Debt to Total Equity Annual | 1.34 | 0.81 | 0.70 | 0.60 | 0.40 | |
| EBDIT Annual Margin % | -0.05 | 14.21 | 24.31 | 21.53 | 18.58 |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| ICICI PRUDENTIAL MULTICAP FUND | 5.3 | 74803185 | - | - |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| ASHOK VISHWANATH HIREMATH | 1.99 | 74803179 | 0 | 0 |
| GODREJ AGROVET LIMITED | 64.76 | 74803182 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| ICICI PRUDENTIAL MULTICAP FUND | 5.3 | 74803185 |
| NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA SMALL CAP FUND | 2.39 | 74803186 |
| Name | Holding Percent | Holding Id |
|---|---|---|
| SHREANS DAGA | 1.9 | 74803199 |
| KAUSHIK DAGA | 1.67 | 74803200 |
| HUF | 1.1 | 74803192 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| Jul 21, 2023 | 1.5 | FINAL | - | Equity Share |
| Jul 19, 2022 | 1.5 | FINAL | - | Equity Share |
| Jul 22, 2021 | 1.5 | FINAL | - | Equity Share |
| Jul 16, 2020 | 1.5 | FINAL | - | Equity Share |
| Jul 18, 2019 | 1.5 | FINAL | - | Equity Share |
| Jul 19, 2018 | 1.5 | FINAL | - | Equity Share |
| Jul 17, 2017 | 1.5 | FINAL | - | Equity Share |
| Sep 15, 2015 | 1.25 | FINAL | - | Equity Share |
| Sep 15, 2014 | 1 | FINAL | - | Equity Share |
| Sep 02, 2013 | 0.75 | FINAL | - | Equity Share |
| Sep 13, 2012 | 0.5 | FINAL | - | Equity Share |
| Sep 15, 2011 | 0.5 | FINAL | - | Equity Share |
| Aug 12, 2010 | 1 | FINAL | - | Equity Share |
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| May 02, 2024 | Audited Results | - |
| Jan 25, 2024 | Quarterly Results | - |
| Oct 27, 2023 | Quarterly Results & Others | - |
| Jul 27, 2023 | Quarterly Results | - |
| May 02, 2023 | Audited Results & Final Dividend | - |
| Jan 30, 2023 | Quarterly Results & Others | Inter alia, the Board may also consider and approve issuance of Debentures or debt securities upto such limit as may be deemed appropriate and approved by the Board. |
| Oct 28, 2022 | Quarterly Results | - |
| Jul 25, 2022 | Quarterly Results | - |
| May 02, 2022 | Audited Results & Final Dividend | - |
| Jan 25, 2022 | Quarterly Results | - |
| Oct 27, 2021 | Quarterly Results | - |
| Jul 28, 2021 | Quarterly Results | - |
| Apr 30, 2021 | Audited Results & Final Dividend | - |
| Jan 25, 2021 | Quarterly Results | - |
| Oct 29, 2020 | Quarterly Results | - |
| Jul 22, 2020 | Quarterly Results | - |
| May 05, 2020 | Audited Results & Final Dividend | - |
| Jan 30, 2020 | Quarterly Results | - |
| Oct 25, 2019 | Quarterly Results | - |
| Jul 26, 2019 | Quarterly Results | - |
| Apr 30, 2019 | Audited Results & Final Dividend | - |
| Jan 25, 2019 | Quarterly Results | - |
| Oct 26, 2018 | Quarterly Results | - |
| Sep 14, 2018 | Amalgamation | inter alia, to consider and approve Scheme of Amalgamation of the Company with Godrej Agrovet Limited (Holding Company). |
| Aug 01, 2018 | Quarterly Results | - |
| May 02, 2018 | Audited Results & Final Dividend | - |
| Jan 31, 2018 | Quarterly Results | - |
| Oct 25, 2017 | Quarterly Results | - |
| Jul 28, 2017 | Quarterly Results | - |
| May 04, 2017 | Audited Results & Final Dividend | - |
| Mar 25, 2017 | Others | Allotted 9,000 (Nine Thousand) Equity Shares of Face Value Rs.10/- each to the employees of the Company upon exercise of 9,000 (Nine Thousand) Options granted to them, at an exercise price of Rs.34/- |
| Jan 25, 2017 | Quarterly Results | - |
| Oct 27, 2016 | Quarterly Results | - |
| Jul 26, 2016 | Quarterly Results | Allotted 21,200 (Twenty One Thousand Two Hundred) Equity Shares of Face Value Rs.10/- each to the employees of the Company on exercise of Options granted to them, at an exercise price of Rs. 34/-. |
| May 04, 2016 | Audited Results | - |
| Jan 29, 2016 | Quarterly Results | 1. Appointment of Mr. Vijay Kashinath Khot as an Additional Independent Director of the Company with immediate effect; 2. Appointment of Dr. Brahma Nand Vyas as an Additional Independent Director. |
| Nov 06, 2015 | Quarterly Results | 1. Appointment Mr. N. B. Godrej as the Chairman of the Company. 2. Appointment of Mr. S. Varadaraj as an Additional Director of the Company. |
| Oct 12, 2015 | Others | Appointment of Mr. N. B. Godrej as Additional Director of the Company with immediate effect. |
| Jul 25, 2015 | Quarterly Results | - |
| May 16, 2015 | Audited Results & Dividend | - |
| Mar 05, 2015 | Re-appointment of Managing Director | Re-appointment of Mr. Janak Rawal as Whole Time Director subject to the approval of members. |
| Jan 31, 2015 | Qtrly Results & Allotment of Equity Shares | To consider allotment of 9,25,925 Equity Shares of Rs. 10/- each fully paid-up at Rs. 108/- per share (including a premium of Rs. 98/- per share) on preferential basis. |
| Dec 19, 2014 | To Consider Allotment of Equity Shares | To consider and approve the issue and allotment of Equity shares on Preferential basis of Rs.10,00,00,000/- (Rupees Ten Crores Only) including premium thereon, |
| Oct 18, 2014 | Quarterly Results | - |
| Aug 09, 2014 | Quarterly Results & Others | To alter Memorandum and Articles of Association of Company to give effect to item to increase the Authorised Capital of the Company. |
| May 30, 2014 | Audited Results & Dividend, Others | 1. Increase in Authorised Capital . 2. To alter Memorandum and Articles of Association of Company to give effect to item no. 3 & 4 above. Revised from 14/05/2014. |
| Jan 24, 2014 | Quarterly Results | - |
| Oct 23, 2013 | Quarterly Results | - |
| Sep 19, 2013 | Allotment of Equity Shares | For approving the Allotment of Equity Shares pursuant to the Conversion of Preferential Warrants convertible into Equity Shares. |
| Aug 12, 2013 | Quarterly Results | - |
| May 24, 2013 | Audited Results & Dividend | - |
| Feb 14, 2013 | Quarterly Results | - |
| Jan 04, 2013 | Conversion of Preferential Warrants | To Consider the Allotment of Equity Shares pursuant to the Conversion of Preferential Warrants convertible into Equity Shares. |
| Nov 12, 2012 | Quarterly Results | - |
| Aug 09, 2012 | Quarterly Results | - |
| May 28, 2012 | Audited Results, Dividend & Others | To appoint Non-Executive & Independent Director. |
| Feb 29, 2012 | Increase in Authorised Capital & Others | To increase Authorized Capital of the Company from Rs. 17,00,00,OOO/- to Rs. 20,00,00,OOO/- & to issuance of 16,00,000 Convertible Warrants into Equity Shares on preferential basis. |
| Feb 14, 2012 | Quarterly Results | - |
| Jan 04, 2012 | Appointment of Whole Time Director | To consider the followings: 1. Appointment of Mr. Janak Rawal as Whole Time Director, subject to the approval of members. 2. Re-appointment of Mr. Ashok V Hiremath as Chairman & Managing Director. |
| Nov 12, 2011 | Quarterly Results | - |
| Aug 10, 2011 | Quarterly Results | - |
| May 27, 2011 | Audited Results & Dividend | - |
| Feb 05, 2011 | Quarterly Results | - |
| Nov 10, 2010 | Quarterly Results | - |
| Aug 05, 2010 | Quarterly Results | - |
| May 24, 2010 | Audited Results & Dividend | - |
| Jan 28, 2010 | Quarterly Results | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
03 May 2024
ASTEC LIFESCIENCES LIMITED - 533138 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Kindly find enclosed the newspaper publication.
02 May 2024
ASTEC LIFESCIENCES LIMITED - 533138 - Intimation For Change In Senior Management Personnel.
Kindly find enclosed the change in senior management Personnel.
02 May 2024
Q4FY24 Quarterly & FY24 Annual Result Announced for Astec Lifesciences Ltd.
Agrochemicals company Astec Lifesciences announced Q4FY24 & FY24 results: Q4FY24 Financial Highlights: The Company reported consolidated total income of Rs 155.8 crore in Q4FY24 as compared to Rs 129.5 crore in Q4FY23 The Company reported consolidated EBITDA of Rs 14.8 crore in Q4FY24 as compared to Rs8.0 crore in the same period last year FY24 Financial Highlights: The Company reported consolidated total income of Rs 463.8 crore in FY24 as compared to Rs 641.2 crore in FY23 The Company reported consolidated EBITDA loss of Rs 0.3 crore in FY24 as compared to profit of Rs 89.3 crore in the same period last year Commenting on the performance, N B Godrej, Chairman, Astec LifeSciences Limited, said:" Astec witnessed a slowdown in its enterprise products portfolio in both domestic as well as global markets. Contract manufacturing (CMO) along with new products development performance, however, was in line with our expectations. Revenues from this segment grew 57% in the quarter due to new product development. During the quarter, Astec maintained a steady focus on new product development along with strategic commitment to long-term R&D; projects." Result PDF
02 May 2024
ASTEC LIFESCIENCES LIMITED - 533138 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Kindly find enclosed the Press Release of the Financial Results for the Quarter and Financial Year ended March 31, 2024.
02 May 2024
ASTEC LIFESCIENCES LIMITED - 533138 - Announcement under Regulation 30 (LODR)-Change in Directorate
Please find enclosed intimation of cessation of Directorship of Mr. Vijay K. Khot, Independent Director of the Company, with effect from 2nd May, 2024.
02 May 2024
ASTEC LIFESCIENCES LIMITED - 533138 - Announcement under Regulation 30 (LODR)-Cessation
Please find enclosed the intimation of cessation of Directorship of Mr. Vijay K. Khot, Independent Director of the Company, with effect from the closure of business hours on 2nd May, 2024.
02 May 2024
ASTEC LIFESCIENCES LIMITED - 533138 - 30Th Annual General Meeting
The 30th (Thirtieth) Annual General Meeting of the Company will be held on Monday, 29th July, 2024, at 4.00 p.m. (IST) by Video Conference / Other Audio Visual Mode.
02 May 2024
ASTEC LIFESCIENCES LIMITED - 533138 - Announcement under Regulation 30 (LODR)-Resignation of Director
Please find enclosed intimation of resignation of Mr. Vijay K. Khot, Independent Director of the Company with effect from closure of business hours on 2nd May, 2024
02 May 2024
ASTEC LIFESCIENCES LIMITED - 533138 - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
Please find enclosed intimation of resignation of Chief Financial Officer with effect from the closure of business hours on 3rd May, 2024
02 May 2024
ASTEC LIFESCIENCES LIMITED - 533138 - Audited Financial Results (Standalone And Consolidated) For The Quarter And Financial Year Ended March 31, 2024.
Please find attached Audited Financial Results for the Quarter and Financial Year ended March 31, 2024
